We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.
Peptides shop · Delta-Sleep Inducing Peptide · Reference sheet

Delta-Sleep Inducing Peptide

Reference sheet · Neuropeptides · CPC catalog code DSIP-001

Identity

Name
Delta-Sleep Inducing Peptide
Catalog code
DSIP-001
Category
Neuropeptides

Physicochemical properties

Sequence
H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH (trifluoroacetate salt)

Handling, storage & reconstitution

Upstream storage
CONDITIONS:**-20 ± 5 °C

General guidance for this class

Reference standards in the Neuropeptides class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.

Mechanism & research applications

Delta-Sleep Inducing Peptide sits within the Neuropeptides research class (CPC reference DSIP-001). Neuropeptides bind GPCRs expressed on central and peripheral neurons — modulating cAMP, calcium, and β-arrestin signaling to shape neurotransmission, network excitability, and behavior. Investigators typically incorporate Delta-Sleep Inducing Peptide as a reference standard, tool ligand, or substrate in the assay contexts listed above. Radioligand binding, cAMP HTRF, calcium mobilization, and in vivo behavior assays.

Studied for

  • GPCR receptor-binding and functional profiling
  • Behavioral pharmacology (rodent models)
  • Pain, mood, and anxiety-circuit research
  • Neuroendocrine feedback studies

Frequently asked

What is Delta-Sleep Inducing Peptide?

Delta-Sleep Inducing Peptide (CPC catalog code DSIP-001) is a synthetic neuropeptide receptor ligand in the neuropeptides category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.

What is Delta-Sleep Inducing Peptide studied for?

Published and internal research programs use Delta-Sleep Inducing Peptide as a reference standard in neuropeptides workflows — for example, gpcr receptor-binding and functional profiling and behavioral pharmacology (rodent models). Human clinical evidence is not established.

Is Delta-Sleep Inducing Peptide FDA-approved for human use?

No. Delta-Sleep Inducing Peptide is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.

How is Delta-Sleep Inducing Peptide typically used in the lab?

In a neuropeptides workflow, Delta-Sleep Inducing Peptide is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Radioligand binding, cAMP HTRF, calcium mobilization, and in vivo behavior assays.

Sources

View full product page →Back to catalog

Related peptides in Neuropeptides

Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.

Neuropeptide Y (3-36), human
Neuropeptide Y (1-24), human
Neuropeptide S (1-10) (human)
Neuropeptide Y (13-36), human
Head Activator Neuropeptide
Neurokinin A / Substance K
CART (62-102), human, rat
Neuropeptide W-23 (human)
Research use only. The peptides referenced on this page are supplied to qualified laboratories for in-vitro or non-human research. They are not drugs, foods, cosmetics, or dietary supplements, are not for human consumption, and are not intended to diagnose, treat, cure, or prevent any disease. Physicochemical values shown here are transcribed from the cited upstream reference sheet(s); confirm with your own certificate of analysis before use.
Ask Dot